LAUSR

Serum AKR1B10 predicts the risk of hepatocellular carcinoma - A retrospective single-center study.

Sign Up to like & get
recommendations!
0 Published in 2019 at "Gastroenterologia y hepatologia"

DOI: 10.1016/j.gastrohep.2019.06.007

Abstract: OBJECTIVES AKR1B10, first cloned from liver cancer tissues, has recently been reported to be up-regulated significantly in hepatocellular carcinoma (HCC) tissues, but the relationship between serum level of AKR1B10 and the risk of HCC is… read more here.

Keywords: hepatocellular carcinoma; serum akr1b10; hcc; hcc patients ... See more keywords